弥漫大B细胞淋巴瘤96例临床及预后分析  

Analysis of the prognosis of 96 cases with diffuse large B cell lymphoma(DLBCL)

作　　者：王军[1] 张新华[1] 周敏[1] 冉启杰[1] 杜光祖[1] 

机构地区：[1]广州军区武汉总医院血液科,湖北武汉430070

出　　处：《现代肿瘤医学》2007年第11期1658-1659,共2页Journal of Modern Oncology

摘　　要：目的:分析多种因素对弥漫大B细胞淋巴瘤(DLBCL)预后的影响。方法:采用Kaplan Meier法分析患者治疗后的生存期,采用Cox比例风险模型分析影响预后的因素。结果:1、2、3和5年生存率Ⅰ、Ⅱ期患者为98.8%、91.5%、87.5%、70.3%;Ⅲ期、Ⅳ期患者为62.1%、55.5%、40.1%、23.8%。结论:年龄、乳酸脱氢酶水平、临床分期、身体状况评分是影响DLBCL预后的重要因素。To analyse the influence factors on the prognosis of diffuse large B cell lymphoma. Methods： Kaplan Meier was used for survival analysis and Cox regression model for prognosistic factors. Results-1,2,3 and 5 year survival rates ： patients in stage Ⅰ、Ⅱ were 9 8.8 % , 91.5 % , 8 7.5 % and 7 0.3 % , stage %;Ⅲ,Ⅳwere 62.1% ,55.5% ,40. 1% and 23.8%. Conclusion： Age, staging, LDH level and KPS are the important factors which affect on diffuse large B cell lymphoma prognosis.

关 键 词：弥漫大B细胞淋巴瘤 生存期 预后 

分 类 号：R733.4[医药卫生—肿瘤]